A
Anand Devaraj
Researcher at National Institutes of Health
Publications - 166
Citations - 7845
Anand Devaraj is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Medicine & Lung cancer. The author has an hindex of 33, co-authored 123 publications receiving 5136 citations. Previous affiliations of Anand Devaraj include Imperial College London & National Health Service.
Papers
More filters
Journal ArticleDOI
A diagnostic cohort study on the accuracy of 18-fluorodeoxyglucose (18FDG) positron emission tomography (PET)-CT for evaluation of malignancy in anterior mediastinal lesions: the DECiMaL study.
Chiara Proli,Paulo Loureiro de Sousa,Simon Jordan,Vladimir Anikin,Anand Devaraj,Susannah Love,Michael Shackcloth,Nikolaos Kostoulas,Kostas Papagiannopoulos,Yama Haqzad,M. Loubani,Francesco Sellitri,Felice Granato,Alexander Bush,Adrian Marchbank,Swetha Iyer,Marco Scarci,Eric Lim +17 more
TL;DR: The results of this study suggest reasonable sensitivity but no specificity implying that a negative PET/CT is useful to rule out the diagnosis of malignant disease whereas a positive result has no value in the discrimination between malignant and benign diseases of the anterior mediastinum.
Journal ArticleDOI
Telephone risk-based eligibility assessment for low-dose CT lung cancer screening
J. Dickson,H. Hall,C. Horst,S. Tisi,P. Verghese,Anne M Mullin,Jonathan Teague,Laura Farrelly,Vicky Bowyer,Kylie Gyertson,F Bojang,Claire Levermore,T. Anastasiadis,K. Sennett,John F. McCabe,Anand Devaraj,Arjun Nair,Neal Navani,Matthew E.J. Callister,Allan Hackshaw,Samantha L Quaife,Sam M. Janes +21 more
TL;DR: Telephone-based risk assessment is an efficient way to optimise selection for LCS appointments but requires further iteration to ensure an equitable approach.
Journal ArticleDOI
False-Negative Results in Lung Cancer Screening-Evidence and Controversies.
TL;DR: In this article, the impact and causes of false-negative lung cancer screening tests, including those related to radiologic evaluation, nodule management protocols, and management decisions made by multidisciplinary teams, are reviewed.
Journal ArticleDOI
Defining growth in small pulmonary nodules using volumetry: results from a "coffee-break" CT study and implications for current nodule management guidelines.
TL;DR: In this paper, the interscan variability in the volumetric measurements of small-sized non-metastatic nodules was established, and it was shown that an increase of 15% in nodule volume on sequential CT may represent true growth, and closer surveillance of these nodules may be warranted.